510(k) K220270

Aspirex Thrombectomy System by C.R. Bard, Inc. — Product Code QEW

K220270 is an FDA 510(k) premarket notification submitted by C.R. Bard, Inc. for the device "Aspirex Thrombectomy System". The FDA issued a decision of Substantially Equivalent on Jun 21, 2022. The device falls under product code QEW (Peripheral Mechanical Thrombectomy With Aspiration), a Class II device regulated under 21 CFR 870.5150. C.R. Bard, Inc. has 645 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jun 21, 2022
Date Received
Jan 31, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Peripheral Mechanical Thrombectomy With Aspiration
Device Class
Class II
Regulation Number
870.5150
Review Panel
CV
Submission Type
510(k)

To mechanically disrupt thrombus and/or debris prior to removal from the peripheral vasculature through aspiration.

Need the full FDA record for C.R. Bard, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K220270. Report a data issue: hello@regdatalab.com.